Australasian Skin Cancer Congress

28 – 30 May 2021

The Star, Gold Coast, Queensland

Better Together

Congress 2021 – May 28th-30th

‘Better Together‘

Our 2021 Congress was held on Friday May 28th to Sunday May 30th at The Star Gold Coast as a hybrid event! We were thrilled to welcome 200 in-person delegates and 200 virtual delegates for this important event.

Our delegates from Australia, New Zealand and around the globe were able to enjoy our exciting program offering a wealth of practical and research knowledge on the primary care diagnosis and treatment of skin lesions.

Our 2021 Australasian Skin Cancer Congress program included presentations from primary care practitioners, oncologists, researchers and pathologists, many of whom are global thought leaders in skin cancer medicine – the people who influence the future of skin cancer medicine diagnosis and treatment.

Our delegates feedback indicates this years Congress was one of our best ever.

Please lock these dates in now for our 2022 Congress- Friday May 20th – Sunday May 22nd 2022.

Congress delegates can access the Watch on Demand session recordings here now!

Platinum Partner

Gold Partners

Featured Speakers

Associate Professor Alex Menzies

Neoadjuvant Therapy and the implications in primary care

How does recent research on neoadjuvant therapy from Melanoma Institute Australia affect primary care practitioners? With most melanomas being diagnosed in the primary care setting what are the implications for referral pathways, potential impact on treatment options and patient management?

Professor Rachael Morton

Where is the map? Creating consistent protocols to manage patients after a primary skin cancer diagnosis.

Professor Rachael Morton will be providing an epidemiological and financial perspective in the compelling first Congress session discussion on creating guidelines for patient follow-up in the primary care setting.

Associate Professor Jonathan Stretch AM

The Shave Biopsy Debate

It’s a commonly used technique, but what are the pros and cons? This panel session features Surgical Oncologist and Deputy Medical Director, Melanoma Institute Australia, A/Prof Professor Jonathan Stretch as well as dermatopathologist Dr Blake O’Brien and a skin cancer GP to discuss.

Professor Pascale Guitera

Rethinking skin surveillance for high-risk melanoma patients

Professor Pascale Guitera– Recent research has demonstrated that it is feasible for a structured surveillance program to be implemented on a large scale in numerous settings, including dermatology clinics and primary care skin cancer clinics. Clinicians at four different clinics in NSW found that two-thirds of new melanomas were detected with the help of total body photography and digital dermoscopy monitoring.

Dr Blake O’Brien

The Shave Biopsy Debate

Dr Blake O’Brien will be presenting a Dermatopathologists perspective in our panel session on the Shave Biopsy Debate. He will be joined by Surgical Oncologist and Deputy Medical Director, Melanoma Institute Australia, A/Prof Professor Jonathan Stretch and a skin cancer GP to discuss.

Dr James Bricknell

Field treatment for Actinic Keratosis

Topical treatment with a Calcipotriol/5-FU mix can be a game changer.
Learn the practical tips to achieve increased patient satisfaction and compliance.

Professor David Whiteman

Skin cancer risk prediction tools – What works for primary care?

Why are there are so many different tools from different organisations? Which one should clinicians use? How do we avoid patient confusion? Will there ever be a single definitive tool? Prof David Whiteman, leading skin cancer researcher and epidemiologist will explain the challenges of skin cancer risk prediction and help primary care practitioners make informed choices about assessing risk.

Professor Tarl Prow

Drug repurposing for skin cancer treatment.

Taking a fresh look at proven and trusted drugs can have unexpected results. Professor Tarl Prow, PhD, Medical Microtechnology Laboratory Head, University of South Australia, will outline how a chance discovery may have a positive change on the future treatment of SCC.

Professor Peter Soyer

Australian Centre of Excellence in Melanoma Imaging and Diagnosis: an update and current studies cancer risk prediction tools

Professor Soyer is a world leader in the field of dermatology with particular expertise in dermatooncology and dermatologic imaging. He will be presenting in a session focussed on the clinical and commercial pros and cons of imaging technology in skin cancer practice – is it improving diagnosis?

Dr Ian Katz

Probability for skin cancer doctors.

Dermatopathologist from Southern Sun Pathology, Dr Ian Katz, will update on probability for skin cancer doctors. What do measures of sensitivity and specificity actually mean?

Professor Rachel Neale

Sun exposure – How much is enough?

This update from the March 2021 Sun Exposure Summit featuring Professor Rachel Neale, the head of the Cancer and Aetiology Group at the QIMR Berghofer Medical Research Institute, will inform how you advise your patients about healthy sun exposure.

Dr Eric Khoo

The role of radiotherapy for field change (IEC) skin and other skin cancers.

Dr Eric Khoo, Radiation Oncologist at Icon Cancer Centre, Gold Coast will address radiotherapy as a treatment modality. Learn which patients to refer, the pros and cons of this treatment paradigm and the broader role of radiotherapy in other less common skin cancer subtypes.

Dr Phil Hayden

Nerve Blocks – Optimising Your Technique

Dr Phil Hayden, SCCA Fellow and Educator, is a highly experienced full time skin cancer clinician based in Cairns. Phil is a passionate believer that safe, high quality skin cancer medicine and surgery can and should be delivered in a primary care setting. Using live close-up images on the big screen, watch as Phil demonstrates how to improve your technique with anaesthetic nerve blocks.

DAY 1 - Friday, 28 May 2021
SESSION 1 9.00 am	Where is the map? Creating consistent protocols to manage patients after a primary skin cancer diagnosis. Introduction - Prof Michael Kimlin The scope of the issue – epidemiological and financial aspects – Prof Rachael Morton, NHMRC Clinical Trials Centre, University of Sydney How are primary care doctors managing patient follow-up right now? What works and what is missing? Dr Paul Martin, Skin Cancer GP, Caboolture Qld
10.30 am	*Morning Tea*
SESSION 2 11.00 am	How much is enough? Sun Exposure Summit 2021 - Prof Rachel Neale, Deputy Coordinator Population Health, QIMR Berghofer Medical Research Institute This update from the March 2021 Sun Exposure Summit will inform how GPs advise patients about healthy sun exposure. Biopsy of nail matrix and nail bed- Dr Helena Rosengren, Senior Lecturer and Skin Cancer Educator James Cook University Efficiency of Detecting New Primary Melanoma Among Individuals Treated in a High-risk Clinic for Skin Surveillance - Prof Pascale Guitera, Dermatologist Melanoma Institute Australia
12.30 pm	*Lunch*
SESSION 3 1.30 pm	Non-surgical treatments - new and emerging options Topical treatment for Actinic Keratosis - Dr James Bricknell FSCCA, Principal Noosa Skin Cancer Surgery The role of radiotherapy for field change (IEC) skin and other skin cancers - Dr Eric Khoo, Radiation Oncologist, Icon Cancer Centre Drug repurposing for skin cancer treatment - Prof Tarl Prow, University of South Australia
3.00 pm	*Afternoon Tea*
SESSION 4 3.30 pm	Calculate, Celebrate and Chuckle Skin cancer risk prediction tools - What works for primary care? Prof David Whiteman Deputy Director, QIMR Berghofer Medical Research Institute Presentation of new SCCA Fellows – Lynette Hunt, CEO Skin Cancer College Australasia See the Funny Side - Scott Williams, The Happy Human
5.10 pm	*Welcome Drinks 2021*

DAY 2 - Saturday, 29 May 2021
SESSION 5 9.00 am	Future directions for primary care skin cancer Neoadjuvant therapy for melanoma - the implications for primary care - A/Prof Alex Menzies, Medical Oncologist, Melanoma Institute Australia Lighthouse or Clubhouse? College Update - Lynette Hunt, CEO Skin Cancer College Australasia
10.30 am	*Morning Tea*
SESSION 6 11.00 am	The Shave Biopsy Debate - It’s a commonly used technique, but what are the pros and cons? A/Prof Jonathon Stretch - Surgical oncologist, Deputy director Melanoma Institute Australia Dr Blake O'Brien - Dermatopathologist, Sullivan Nicolaides Pathology Dr Jim Muir - Dermatologist, Brisbane Qld Dr Solange Green - Skin Cancer GP, Brisbane Qld Q&A panel session
12.30 pm	*Lunch*
SESSION 7 1.30 pm	Nerves and Numbers Nerve Blocks - Optimising your technique - Dr Phil Hayden FSCCA, Skin Cancer GP, Cairns Qld Probability for Skin Cancer Doctors – What do measures of sensitivity and specificity actually mean? - Dr Ian Katz, Dermatopathologist, Southern Sun Pathology
3.00 pm	*Afternoon Tea*
SESSION 8 3.30 pm	Melanoma - State of the Nation Improving support for people with melanoma and skin cancer in rural and regional Australia - Ms Tiiu Sildva, Clinical Research Associate, Melanoma and Skin Cancer Trials Ltd State of the Nation – A Report into Melanoma, Ms Victoria Beedle, CEO Melanoma Patients Australia Discussion forum - The role of primary care in improving outcomes for melanoma patients
7.30 pm	*Congress Dinner*

DAY 3 - Sunday, 30 May 2021
SESSION 9 9.00 am	Skin imaging in skin cancer practice - The bigger picture An update on the latest technology, is it improving diagnosis? The clinical and commercial pros and cons of imaging technology in skin cancer practice. Canfield TBP in a General Practice setting - Dr Vin Rajeswaran, Principal, FNQH Skin Cancer Clinic, Cairns Qld Fotofinder ATBM trial in a General Practice setting - Dr Jeremy Hudson – Clinical Director, North Queensland Skin Centre, Townsville Qld Australian Centre of Excellence in Melanoma Imaging and Diagnosis: an update and current studies - Prof Peter Soyer
10.30 am	*Morning Tea*
SESSION 10 11.00 am	See the light! - PDT in primary practice An update on PDT systems. What works, patient feedback and clinical benefits. Inspiration - Dr Franz Strydom FSCCA, Medical Director, Skinspots Tauranga NZ Modification - Dr Roland Lotsu, Principal, St Joseph Skin Cancer Centre, Wellington NZ Combination - Dr Richard Johns, FSCCA, Practice Principal, Kenmore Clinics, Kenmore Qld
12.30 pm	EVENT CLOSE

Program content is subject to change.

Welcome back to The Star, Gold Coast.

This stunning location, set among lush tropical gardens, is the home of the Australasian Skin Cancer Congress. We can’t wait to see you, Better Together, at The Star in 2021.

With its luxurious accommodation and spa, iconic bars, restaurants and entertainment precincts, alongside the thrills of a world-class casino, The Star Gold Coast is Australia’s five-star fun-parlour.

Special rates for Australasian Skin Cancer Congress delegates start at $279 (AUD) per night for a Superior Deluxe Room. This special rate is available for 3 days pre and post Congress.

Rooms at this rate are limited and will book fast. Click here or phone +617 5592 8130 to book accommodation and quote discount code SCC190521.

RESTAURANT DISCOUNT

In addition, will also receive a 10% discount to all food & beverage outlets (excludes Nineteen on weekends and Kiyomi), and The Shop @ The Star upon presentation of conference lanyard. This offer is valid for conference dates and for bookings up to 9 guests.

Book Here